The PennZone

  • Home
  • Entertainment
  • Marketing
  • Music
  • Non-profit
  • Books
  • Education
  • Automotive
  • Sports

Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
The PennZone/10123847

Trending...
  • Slotozilla Reports Strong Growth in Q2 2026
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
  • Kellyn Endorses National Push to Expand Food is Medicine
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ -- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.

ConneX®,  the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.

Greenphire has also continued to evolve its ClinCard solution, the industry-leading method for automating participant payments and reimbursements, driving operational efficiency for sites and improved experience for participants around the world. The ClinCard portal is now translated into 17 different languages, including French, Polish, and Spanish. The company also initiated a dedicated site training team with EU and APAC time zones supported, demonstrating its commitment and motivation to provide a high quality and user-friendly experience for sites around the world.

More on The PennZone
  • Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
  • RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Grace Montessori School Earns Prestigious American Montessori Society Accreditation

"COVID-19 was a catalyst that accelerated the clinical trial industry towards embracing technology solutions, such as ClinCard and ConneX," said Jim Murphy, CEO, Greenphire. "Sponsors, CROs and sites quickly appreciated the immense benefits of adding innovative solutions to support their trials, such as higher patient engagement and retention and improved operational efficiencies. We are proud to support this digital movement and enhance the experience for sites in every corner of the globe."

Recognized as leaders in clinical digital innovations in the United Kingdom, having their EU headquarters in Nottingham and more than 1,000 sites supported in the country, Greenphire executives have been asked to host an interactive panel on this growing trend.

Hosted by the Society for Clinical Research Sites (SCRS), the one-hour session titled: Digital Innovation in Clinical Trials: A Conversation with UK Stakeholders, will also feature the unique perspectives of clinical trial site, The University of Aberdeen, and advocate and patient engagement advisor, Trishna Bharadia.

This virtual event is scheduled for May 4, 2021 at 10:00 AM ET and will take a deep dive into current trends and how technology, together with training, is driving the future of clinical trials.

Presenters include:
  • Angela La Ronde, Panel Moderator, Director of Relationship Management, Greenphire UK
  • Trishna Bharadia, Advocate and Patient Engagement Advisor
  • Shaun Treweek, Professor, University of Aberdeen
  • Ben Gordon, Site Trainer, Greenphire UK

For more information or to register for the event visit: https://bit.ly/3tLmfws

More on The PennZone
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
  • NaturismRE expands international research programme with Health & Wellbeing Survey
  • L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach

Greenphire is also a co-sponsor of the 11th Annual OCT Europe (Outsourcing in Clinical Trials). The virtual event, hosted from May 5-6, 2021, will center on how to leverage partnerships and expertise to maximize trial success. For more information, visit: https://www.arena-international.com/octeurope/

About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire's EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Alyson Kuritz
908-892-7149
[email protected]

SOURCE Greenphire

Related Links

http://www.greenphire.com
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • Tina Hasselbusch, Turnstone Creative Co-founder and Chief Executive Officer, Named to LVB 300
  • Pittsburgh Family Law Attorneys at Pollock Begg Earn Top Honors in 2027 Best Lawyers Guide
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Slotozilla Reports Strong Growth in Q2 2026
  • Eric Snyder, President and Chief Executive Officer of Keystone Consulting Engineers Named to LVB 300
  • Philadelphia's Girls Anthem to Host The Locker Room Experience Pop-Up for Young Women
  • Flexible Plan Investments Names Carl Resnick President
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
  • Sharon Pinkenson Chosen as Philly Girl Top 40 Winner
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 775
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments - 111
  • Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH - 106
  • Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
  • $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Crossroads4Hope Announces The Lipschutz Women's Fund

Similar on PennZone

  • Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Slotozilla Reports Strong Growth in Q2 2026
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us